HomeCompareALKEF vs MRK

ALKEF vs MRK: Dividend Comparison 2026

ALKEF yields 198.02% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ALKEF wins by $112.64M in total portfolio value
10 years
ALKEF
ALKEF
● Live price
198.02%
Share price
$1.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$112.70M
Annual income
$56,534,499.65
Full ALKEF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ALKEF vs MRK

📍 ALKEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodALKEFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ALKEF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ALKEF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALKEF
Annual income on $10K today (after 15% tax)
$16,831.68/yr
After 10yr DRIP, annual income (after tax)
$48,054,324.70/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ALKEF beats the other by $48,045,996.29/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALKEF + MRK for your $10,000?

ALKEF: 50%MRK: 50%
100% MRK50/50100% ALKEF
Portfolio after 10yr
$56.38M
Annual income
$28,272,148.89/yr
Blended yield
50.15%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ALKEF
No analyst data
Altman Z
8.3
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALKEF buys
0
MRK buys
0
No recent congressional trades found for ALKEF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricALKEFMRK
Forward yield198.02%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$112.70M$56.8K
Annual income after 10y$56,534,499.65$9,798.13
Total dividends collected$106.15M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ALKEF vs MRK ($10,000, DRIP)

YearALKEF PortfolioALKEF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$30,502$19,801.98$11,206$366.19+$19.3KALKEF
2$89,086$56,448.56$12,650$502.35+$76.4KALKEF
3$249,403$154,080.96$14,407$694.19+$235.0KALKEF
4$670,003$403,142.26$16,585$967.82+$653.4KALKEF
5$1,729,066$1,012,162.66$19,342$1,363.89+$1.71MALKEF
6$4,291,289$2,441,188.37$22,913$1,947.19+$4.27MALKEF
7$10,253,990$5,662,310.92$27,662$2,823.89+$10.23MALKEF
8$23,616,660$12,644,890.45$34,159$4,173.35+$23.58MALKEF
9$52,487,868$27,218,041.68$43,337$6,308.80+$52.44MALKEF
10$112,696,518$56,534,499.65$56,776$9,798.13+$112.64MALKEF

ALKEF vs MRK: Complete Analysis 2026

ALKEFStock

Alkane Resources Limited operates as a gold production company in Australia. It explores for gold, copper, nickel, zinc, and silver deposits. The company holds various interests in the Tomingley Gold project that consists of four gold deposits; and the Northern Molong Porphyry Project, which covers an area of 115 square kilometers located in the Central West of New South Wales. Its exploration projects comprise Boda and Kaiser, Cudal, Peak Hill, Elsienora, Rockley, Armstrongs, Trangie, and Mt Conqueror projects. The company also invests in junior gold mining companies and projects. Alkane Resources Limited was incorporated in 1969 and is headquartered in West Perth, Australia.

Full ALKEF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ALKEF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALKEF vs SCHDALKEF vs JEPIALKEF vs OALKEF vs KOALKEF vs MAINALKEF vs JNJALKEF vs ABBVALKEF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.